Table of Contents
1. Preface
2. Assumptions and Acronyms Used
3. Research Methodology
4. Executive Summary
5. Market Overview
6. Global Market Analysis, by Test Type
- 6.1. Serology Test
- 6.2. Stool Antigen Test (SAT)
- 6.3. Urea Breath Test (UBT)
- 6.4. Endoscopy Test Types
7. Global Market Analysis, by Test Method
- 7.1. Laboratory-based Tests
- 7.2. Point-of-Care Tests
8. Global Market Analysis, by End-user
- 8.1. Hospitals
- 8.2. Clinics
- 8.3. Diagnostic Laboratories
9. Global Market Analysis and Forecasts, by Region
- 9.1. North America
- 9.2. Europe
- 9.3. Asia Pacific
- 9.4. Latin America
- 9.5. Middle East & Africa
10. North America Market Analysis
11. Europe Market Analysis
12. Asia Pacific Market Analysis
13. Latin America Market Analysis
14. Middle East & Africa Market Analysis
15. Competitive Landscape
- 15.1. DiaSorin S.p.A.
- 15.2. Meridian Bioscience, Inc.
- 15.3. Exalenz Bioscience Ltd.
- 15.4. Alere
- 15.5. Thermo Fisher Scientific
- 15.6. Biomerica, Inc.
- 15.7. Certest Biotec S.L.
- 15.8. Sekisui Diagnostics
- 15.9. CorisBioconcept SPRL
- 15.10. Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd.
List of Tables
Table 01: Global Market Value (US$ Mn) Forecast, by Non-invasive Test Type, 2023 to 2033
Table 02: Global Market Value (US$ Mn) Forecast, by Test Method, 2023 to 2033
Table 03: Global Market Value (US$ Mn) Forecast, by End User, 2023 to 2033
Table 04: Global Market Value (US$ Mn) Forecast, by Region, 2023 to 2033
Table 05: North America Market Revenue (US$ Mn) Forecast, by Country, 2023 to 2033
Table 06: North America Market Revenue (US$ Mn) Forecast, by Non-invasive Test Type, 2023 to 2033
Table 07: North America Market Revenue (US$ Mn) Forecast, by Test Method, 2023 to 2033
Table 08: North America Market Revenue (US$ Mn) Forecast, by End User, 2023 to 2033
Table 09: Europe Market Revenue (US$ Mn) Forecast, by Country, 2023 to 2033
Table 10: Europe Market Revenue (US$ Mn) Forecast, by Non-invasive Test Type, 2023 to 2033
Table 11: Europe Market Revenue (US$ Mn) Forecast, by Test Method, 2023 to 2033
Table 12: Europe Market Revenue (US$ Mn) Forecast, by End User, 2023 to 2033
Table 13: Asia Pacific Market Revenue (US$ Mn) Forecast, by Country, 2023 to 2033
Table 14: Asia Pacific Market Revenue (US$ Mn) Forecast, by Non-invasive Test Type, 2023 to 2033
Table 15: Asia Pacific Market Revenue (US$ Mn) Forecast, by Test Method, 2023 to 2033
Table 16: Asia Pacific Market Revenue (US$ Mn) Forecast, by End User, 2023 to 2033
Table 17: Latin America Market Revenue (US$ Mn) Forecast, by Country, 2023 to 2033
Table 18: Latin America Market Revenue (US$ Mn) Forecast, by Non-invasive Test Type, 2023 to 2033
Table 19: Latin America Market Revenue (US$ Mn) Forecast, by Test Method, 2023 to 2033
Table 20: Latin America Market Revenue (US$ Mn) Forecast, by End User, 2023 to 2033
Table 21: Middle East & Africa Market Revenue (US$ Mn) Forecast, by Country, 2023 to 2033
Table 22: Middle East & Africa Market Revenue (US$ Mn) Forecast, by Non-invasive Test Type, 2023 to 2033
Table 23: Middle East & Africa Market Revenue (US$ Mn) Forecast, by Test Method, 2023 to 2033
Table 24: Middle East & Africa Market Revenue (US$ Mn) Forecast, by End User, 2023 to 2033
List of Figures
Figure 01: Prevalence of Helicobacter Pylori, North America, 2022
Figure 02: Prevalence of Helicobacter Pylori, Europe, 2022
Figure 03: Prevalence of Helicobacter Pylori, Asia Pacific, 2022
Figure 04: Prevalence of Helicobacter Pylori, Latin America, 2022
Figure 05: Prevalence of Helicobacter Pylori, Middle East & Africa, 2022
Figure 06: Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Size (US$ Mn) Forecast, 2023 to 2033
Figure 07: Opportunity Map, by Non-invasive Test Type and Test Method, 2022
Figure 08: Opportunity Map, by End User, 2022
Figure 09: Global Market Value Share, by Region (2022)
Figure 10: Global Market Value Share, by Test Method (2022)
Figure 11: Global Market Value Share, by Non-Invasive Test Type (2022)
Figure 12: Global Market Value Share, by End-user (2022)
Figure 13: Global Market Value Share, by Non-invasive Test Type, 2020 and 2026
Figure 14: Global Market Revenue (US$ Mn), by Serology Test, 2023 to 2033
Figure 15: Global Market Revenue (US$ Mn), by SAT, 2023 to 2033
Figure 16: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by UBT, 2023 to 2033
Figure 17: Global Market Attractiveness, by Non-invasive Test Type, 2023 to 2033
Figure 18: Global Market Value Share, by Test Method, 2020 and 2026
Figure 19: Global Market Attractiveness, by Test Method, 2023 to 2033
Figure 20: Global Market Revenue (US$ Mn), by Laboratory Based Tests, 2023 to 2033
Figure 21: Global Market Revenue (US$ Mn), by Point-of-Care Tests, 2023 to 2033
Figure 22: Global Market Value Share, by End User, 2020 and 2026
Figure 23: Global Market Attractiveness, by End User, 2023 to 2033
Figure 24: Global Market Revenue (US$ Mn), by Hospitals, 2023 to 2033
Figure 25: Global Market Revenue (US$ Mn), by Clinics, 2023 to 2033
Figure 26: Global Market Revenue (US$ Mn), by Diagnostic Labs, 2023 to 2033
Figure 27: Global Market Value Share (%), by Region, 2020 and 2026
Figure 28: Global Market Attractiveness, by Region, 2023 to 2033
Figure 29: North America Market Value Share, by Country, 2020 and 2026
Figure 30: North America Market Attractiveness, by Country, 2023 to 2033
Figure 31: North America Market Value Share, by Non-invasive Test Type, 2020 and 2026
Figure 32: North America Market Attractiveness, by Non-invasive Test Type, 2023 to 2033
Figure 33: North America Market Value Share, by Test Method, 2020 and 2026
Figure 34: North America Market Attractiveness, by Test Method, 2023 to 2033
Figure 35: North America Market Value Share, by End User, 2020 and 2026
Figure 36: North America Market Attractiveness, by End User, 2023 to 2033
Figure 37: Europe Market Value Share, by Country, 2020 and 2026
Figure 38: Europe Market Attractiveness, by Country, 2023 to 2033
Figure 39: Europe Market Value Share, by Non-invasive Test Type, 2020 and 2026
Figure 40: Europe Market Attractiveness, by Non-invasive Test Type, 2023 to 2033
Figure 41: Europe Market Value Share, by Test Method, 2020 and 2026
Figure 42: Europe Market Attractiveness, by Test Method, 2023 to 2033
Figure 43: Europe Market Value Share, by End User, 2020 and 2026
Figure 44: Europe Market Attractiveness, by End User, 2023 to 2033
Figure 45: Asia Pacific Market Value Share, by Country, 2020 and 2026
Figure 46: Asia Pacific Market Attractiveness, by Country, 2023 to 2033
Figure 47: Asia Pacific Market Value Share, by Non-invasive Test Type, 2020 and 2026
Figure 48: Asia Pacific Market Attractiveness, by Non-invasive Test Type, 2023 to 2033
Figure 49: Asia Pacific Market Value Share, by Test Method, 2020 and 2026
Figure 50: Asia Pacific Market Attractiveness, by Test Method, 2023 to 2033
Figure 51: Asia Pacific Market Value Share, by End User, 2020 and 2026
Figure 52: Asia Pacific Market Attractiveness, by End User, 2023 to 2033
Figure 53: Latin America Market Value Share, by Country, 2020 and 2026
Figure 54: Latin America Market Attractiveness, by Country, 2023 to 2033
Figure 55: Latin America Market Value Share, by Non-invasive Test Type, 2020 and 2026
Figure 56: Latin America Market Attractiveness, by Non-invasive Test Type, 2023 to 2033
Figure 57: Latin America Market Value Share, by Test Method, 2020 and 2026
Figure 58: Latin America Market Attractiveness, by Test Method, 2023 to 2033
Figure 59: Latin America Market Value Share, by End User, 2020 and 2026
Figure 60: Latin America Market Attractiveness, by End User, 2023 to 2033
Figure 61: Middle East & Africa Market Value Share, by Country, 2020 and 2026
Figure 62: Middle East & Africa Market Attractiveness, by Country, 2023 to 2033
Figure 63: Middle East & Africa Market Value Share, by Non-invasive Test Type, 2020 and 2026
Figure 64: Middle East & Africa Market Attractiveness, by Non-invasive Test Type, 2023 to 2033
Figure 65: Middle East & Africa Market Value Share, by Test Method, 2020 and 2026
Figure 66: Middle East & Africa Market Attractiveness, by Test Method, 2023 to 2033
Figure 67: Middle East & Africa Market Value Share, by End User, 2020 and 2026
Figure 68: Middle East & Africa Market Attractiveness, by End User, 2023 to 2033
Figure 69: Global Helicobacter Pylori (H. Pylori) Non-invasive Testing, Company Share Analysis, 2022 (Estimated)
Figure 70: DiaSorin S.p.A Revenue (US$ Mn) and Y-o-Y Growth (%), 2018 to 2022
Figure 71: DiaSorin S.p.A Breakdown of Net Sales (%), by Region, 2022
Figure 72: Meridian Bioscience, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2018 to 2022
Figure 73: Meridian Bioscience, Inc. Breakdown of Net Sales (%), by Business Segment, 2022
Figure 74: Exalenz Bioscience Ltd. Revenue (US$ Mn) and Y-o-Y Growth (%), 2018 to 2022
Figure 75: Exalenz Bioscience Ltd. R&D Expenditure (US$ Mn), 2018-2022
Figure 76: Alere (Abbott) Revenue (US$ Mn) and Y-o-Y Growth (%), 2018 to 2022
Figure 77: Alere (Abbott) Breakdown of Net Sales (%), by Business Segment, 2022
Figure 78: Thermo Fisher Scientific Revenue (US$ Mn) and Y-o-Y Growth (%), 2018 to 2022
Figure 79: Thermo Fisher Scientific Breakdown of Net Sales (%), by Business Segment, 2022
Who worked on this report
Preview the report firsthand - request a free sample
Free SampleGet the brochure for pricing and purchase details
Download PDF